Hims and Hers Closes Apostrophe Following Stock Decline

March 7, 2025 - 19:22

Hims and Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public telehealth company. The decision comes in the wake of a significant drop in stock value, which was exacerbated by the recent FDA decision regarding a weight-loss drug.

The closure of Apostrophe marks a notable shift in Hims and Hers' strategy, reflecting the challenges faced in the competitive telehealth and dermatology markets. The company has been navigating a series of hurdles, including regulatory scrutiny and evolving consumer preferences, which have put pressure on its overall business model.

As Hims and Hers pivots away from its dermatology segment, stakeholders are left to ponder the implications for its future growth and profitability. The company will now focus on its core offerings, aiming to stabilize its financial performance while addressing the changing landscape of telehealth services.